News
Why Eylea Is Still Regeneron Pharmaceuticals' Most Important Drug
Aging baby boomers are turning 65 years old at a pace of 10,000 per day, and that's causing an increase in the diagnosis of common causes of vision loss, including age-related macular degeneration....
3 Top Stocks Under $5
Tiny stocks don't get a lot of love on Wall Street -- and by tiny I mean companies that have a share price of under $5. According to the Securities and Exchange Commission, any stock that trades....
3 Most Promising Cancer Drugs in Late-Stage Development
Progress marches on in the fight against cancer. While more biosimilars are becoming available for top cancer drugs of the past, biopharmaceutical companies are developing newer and more powerful....
3 High-Yield Pharmaceutical Stocks
The pharmaceutical industry is a natural hunting ground for reliable income stocks, since people buy drugs in good times and in bad. But which high-yield dividend stocks are actually worthy of....
CVS Health Hopes Partnerships Will Power Growth
CVS Health Corp (NYSE: CVS) has had a rough go of it during the past year. Over the last twelve months, shares in the pharmaceutical drug store chain and pharmacy benefit manager (PBM) have dipped....
Here's Why Community Health Systems Surged Today
Shares of Community Health Systems (NYSE: CYH), a major operator of U.S. hospitals, jumped 12.8% on Monday before finishing the session about 8.7% higher. The ASL Strategic Value Fund sent a....
Better Buy: Veeva Systems Inc. vs. Cerner Corporation
Veeva Systems (NYSE: VEEV) and Cerner (NASDAQ: CERN) rank as two of the most successful healthcare technology companies of the past five years. Veeva's customer relationship management (CRM) and....
Better Buy: AbbVie Inc. vs. Pfizer Inc.
There's no question that AbbVie (NYSE: ABBV) shareholders have been happier campers than Pfizer (NYSE: PFE) shareholders in recent years. Whether you compare the two drug stocks over five years,....
This Stock Could Be the Tesla of Healthcare
Some farsighted (or just plain lucky) investors bought shares of Tesla Motors (NASDAQ: TSLA) early on. They took a huge risk, but that risk paid off. Tesla stock is up nearly 1,400% since the....
3 Reasons Obamacare Premiums Are Set to Skyrocket in 2018
The Affordable Care Act (ACA), which is more affably known as Obamacare, is arguably the hallmark legislation of former President Barack Obama. While it's been controversial since its passage, and....
Intuitive Surgical Stock Split: Everything You Need to Know
Robotic surgical pioneer Intuitive Surgical, Inc. (NASDAQ: ISRG) has had quite a run lately. So far this year, shares are up 56%, and over the past three years, the stock has more than doubled.....
Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant
Pfizer, Inc. (NYSE: PFE) scored another cancer drug victory this past week when the FDA green-lighted Besponsa, a drug that battles back against a rare and deadly type of leukemia. The approval....
Here's How Much $10,000 Invested in Pfizer in 1977 Is Worth Now
Forty years is a long time. But it's not an unimaginably long time. For many Americans, 40 years is roughly the length of time they will spend or have spent in the workforce.Those years will end....
3 Top Biotech Stocks Under $5
The biotech field is littered with stocks under $5 that probably won't walk away from the crash landings that made them look so cheap. You'll be glad to know that sifting through the wreckage to....
Up 187% in 2017, Is Exact Sciences Corp. Stock Still a Buy?
Exact Sciences (NASDAQ: EXAS) investors are having a year to remember. Shares of the colon cancer detection company have been on an absolute tear in 2017, rising more than 187%. But after the....
These Stocks Have Tripled This Year
The stock market has made a lot of people rich since 2009, as several major benchmarks have tripled or even quadrupled during the past eight years. Yet for individual stocks, gains can come a lot....
3 Healthcare Stocks I'll Hold Forever
Fund managers who need to look busy might hate to admit it, but doing nothing is usually the best course of action for most investors. That doesn't mean it's a good idea to look the other way when....
Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?
It may not get the attention as often as larger-cap biotech stocks like Celgene Corp. (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD), but a bunch of recent drug approvals could soon change that
How Safe Is Johnson & Johnson's Dividend?
Johnson & Johnson (NYSE: JNJ) is one of the best-known companies in America, with most consumers making its over-the-counter products a staple of their medicine cabinets. Yet Johnson & Johnson has
The 3 Best Stocks in Healthcare
If you're looking for great investing opportunities, you really need to check out healthcare stocks. From biotech to health insurance to medical devices, there are plenty of solid choices. But which
3 Dividend Healthcare Stocks
The rapid aging of the world's population should ensure that demand for healthcare products and services remains on the rise for decades to come. But how can income investors take advantage of the
One Company That's Set to Win From Precision Medicine
In the last few decades, incredible strides have been made in genome typing and precision medicine technology. What used to cost hundreds of thousands of dollars is now available for $100, opening up
Why Gilead Sciences Might Not Make an Oncology Acquisition
Is Gilead Sciences (NASDAQ: GILD) backing away from its plans to acquire a smaller biotech focusing on oncology? That could be the case. Gilead CEO John Milligan reportedly told Leerink analyst
The Hidden Gem in Novavax's Pipeline You'll Want to Watch
If you've looked into Novavax (NASDAQ: NVAX), you know the clinical-stage biotech's primary focus is on its experimental RSV F vaccine. Novavax has had its fair share of ups and downs with that
Why I Love Celgene Corporation
Stocks aren't like children. It's not a problem at all if you don't love each stock in your investment portfolio equally. You can have favorites without even the smallest amount of guilt.In my case